• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Study of 1,4,5,8-Naphthalenetetracarboxdiimide (CAS: 5690-24-4) for Biomedical Applications

1,4,5,8-Naphthalenetetracarboxdiimide (NTCDI, CAS: 5690-24-4) is a naphthalene-based organic compound with a unique tetra-carboxdiimide structure, which has garnered significant attention in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential as a versatile building block for the development of novel biomaterials, drug delivery systems, and therapeutic agents. This research brief synthesizes the latest findings on NTCDI, focusing on its synthesis, functionalization, and applications in biomedical sciences.

One of the key advancements in NTCDI research involves its role as a supramolecular scaffold for drug delivery. A 2023 study published in the Journal of the American Chemical Society demonstrated that NTCDI derivatives can self-assemble into stable nanostructures capable of encapsulating hydrophobic drugs. The study highlighted the compound's ability to enhance drug solubility and bioavailability, particularly for anticancer agents like doxorubicin. The researchers attributed this property to NTCDI's planar aromatic core and its ability to form π-π stacking interactions with drug molecules.

In addition to drug delivery, NTCDI has shown promise in the development of bioimaging probes. A recent publication in Advanced Materials reported the synthesis of NTCDI-based fluorescent probes with tunable emission properties. These probes exhibited high photostability and selectivity for specific cellular organelles, making them valuable tools for live-cell imaging. The study also noted that the probes' fluorescence could be modulated by varying the substituents on the NTCDI core, offering a versatile platform for designing customized imaging agents.

Another exciting development is the exploration of NTCDI's antimicrobial properties. A 2024 study in Nature Communications investigated the compound's efficacy against multidrug-resistant bacterial strains. The researchers found that NTCDI derivatives could disrupt bacterial cell membranes by interacting with phospholipids, leading to cell lysis. Importantly, these derivatives showed low cytotoxicity toward mammalian cells, suggesting their potential as safe and effective antimicrobial agents. The study also identified specific structural modifications that could enhance NTCDI's antibacterial activity while minimizing resistance development.

Beyond its biomedical applications, NTCDI has also been studied for its electronic properties. A collaborative research effort between academic and industrial labs, published in Chemical Science, explored the use of NTCDI as an electron-accepting moiety in organic semiconductors. The study revealed that NTCDI-based materials exhibited high electron mobility and stability, making them suitable for applications in flexible electronics and biosensors. These findings open new avenues for integrating NTCDI into multifunctional devices that combine electronic and biological functionalities.

In conclusion, recent research on 1,4,5,8-Naphthalenetetracarboxdiimide (CAS: 5690-24-4) underscores its versatility and potential in chemical biology and pharmaceutical sciences. From drug delivery and bioimaging to antimicrobial therapy and electronic materials, NTCDI continues to inspire innovative applications. Future studies are expected to focus on optimizing its structure-activity relationships and exploring its interactions with biological systems in greater detail. As the field progresses, NTCDI-based technologies may soon transition from the lab to clinical and industrial settings, addressing critical challenges in healthcare and biotechnology.

• 81-33-4(3,4,9,10-Perylenetetracarboxylic-diimide)
• 81-83-4(1,8-Naphthalimide)
• 2896-24-4(3-benzyl-3-azatricyclo7.3.1.0^{5,13}trideca-1(13),5,7,9,11-pentaene-2,4-dione)
• 106897-63-6(Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone,2,7-bis(phenylmethyl)-)
• 52000-81-4(n,n'-dibenzyl-perylene-tetracarbonic acid, diamide)
• 5521-31-3(C.I.Vat Red 23)
• 2382-08-3(1H-Benz[de]isoquinoline-1,3(2H)-dione,2-methyl-)
• 22245-63-2(3H-Phenanthro[3,4,5-defg]isoquinoline-3,5(4H)-dione(9CI))
• 20958-66-1(N,N'-Dimethyl-1,4,5,8-naphthalenetetracarboxylicdiimide)
• 6424-79-9(Dibenzo[h,h']phenanthro[2,1,10-def:7,8,9-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone)